A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Conditions
Malignant Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Siqing Fu, MD,PhD)NEXT Oncology, San Antonio, Texas, United States
Contact: Study coordinator (David Sommerhalder, MD)NEXT Virginia, Fairfax, Virginia, United States
Contact: Study coordinator (Alexander Spira, MD)Anhui Provincial Cancer Hospital, Hefei, Anhui, China
Contact: Study coordinator (Yueyin Pan)Contact: Principal Investigator (Yueyin Pan)Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Minglei Zhuo)Contact: Principal Investigator (Minglei Zhuo)The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Contact: Study coordinator (Chengzhi Zhou)Contact: Principal Investigator (Chengzhi Zhou)Hubei Cancer Hospital, Wuhan, Hubei, China
Contact: Study coordinator (Bin Yang)Contact: Principal Investigator (Bin Yang)Hunan Cancer Hospital, Changsha, Hunan, China
Contact: Study coordinator (Lin Wu, MD)Contact: Principal Investigator (Lin Wu)The First Affiliated Hospital of Nanchang University - Donghu District, Nanchang, Jiang, China
Contact: Study coordinator (Yong Li)Contact: Study coordinator (Pu Li)Contact: Principal Investigator (Yong Li)Contact: Principal Investigator (Pu Li)Linyi Cancer Hospital, Linyi, Shandong, China
Contact: Study coordinator (Janhua Shi)Contact: Principal Investigator (Jianhua Shi)Shanghai Tenth People's Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Xiaojun Chen)Contact: Principal Investigator (Xiaojun Chen)West China Hospital, Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (Ma Ji)Contact: Principal Investigator (Ji Ma)Sir Run Run Shaw Hospital - Zhejiang University School of Med, Hangzhou, Zhejiang, China
Contact: Study coordinator (Haizhou Lou)Contact: Principal Investigator (Haizhou Lou)The First Affiliated Hospital - Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Jianya Zhou)Contact: Principal Investigator (Jianya Zhou)The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Yuan Ying)Contact: Principal Investigator (Ying Yuan)Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang, China
Contact: Study coordinator (Dongqing Lv)Contact: Principal Investigator (Dongqing Lv)Beijing Cancer Hospital, Beijing, China, Beijing, China
Contact: Study coordinator (Lin Shen)Contact: Principal Investigator (Lin Shen, MD)Shanghai Chest Hospital, Shanghai, China, Shanghai, China
Contact: Study coordinator (Shun Lu)Contact: Principal Investigator (Shun Lu, MD)Shanghai Zhongshan Hospital, Shanghai, China, Shanghai, China
Contact: Study coordinator (Tianshu Liu)Contact: Principal Investigator (Tianshu Liu, MD)
Study leads
Cindy Li
Study Director
Tyligand Bioscience (Shanghai) Limited